bz-423 has been researched along with Leukemia, Myeloid, Acute in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altucci, L; Balliu, M; Carafa, V; Cellai, C; Guandalini, L; Laurenzana, A; Matucci, R; Miniati, D; Nebbioso, A; Paoletti, F; Romanelli, MN; Torre, E | 1 |
1 other study(ies) available for bz-423 and Leukemia, Myeloid, Acute
Article | Year |
---|---|
The new low-toxic histone deacetylase inhibitor S-(2) induces apoptosis in various acute myeloid leukaemia cells.
Topics: Acetylation; Animals; Apoptosis; Benzodiazepines; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Fluorometry; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Leukemia, Myeloid, Acute; Mice; Reactive Oxygen Species; Receptors, GABA-A; Toxicity Tests, Acute | 2012 |